0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global CMO Peptide Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-9C10180
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global CMO Peptide Market Research Report 2022
BUY CHAPTERS

Global CMO Peptide Market Research Report 2025

Code: QYRE-Auto-9C10180
Report
February 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

CMO Peptide Market Size

The global market for CMO Peptide was valued at US$ 3601 million in the year 2024 and is projected to reach a revised size of US$ 9425 million by 2031, growing at a CAGR of 15.0% during the forecast period.

CMO Peptide Market

CMO Peptide Market

Peptides are synthesized by coupling the carboxyl group of one amino acid to the amino group of another amino acid molecule. Due to the possibility of unintended reactions, protecting groups are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.
The customized peptide synthesis market is driven by the growing demand for peptides in various fields, including pharmaceuticals, biotechnology, and research. Customized peptides are essential tools for drug development, therapeutic applications, and biochemical research. The increasing focus on personalized medicine and targeted therapies further propels market growth. Moreover, advancements in peptide synthesis technologies and the availability of automated synthesis platforms have improved the efficiency and scalability of customized peptide production. However, challenges include the complexity of synthesizing certain peptides, the need for stringent quality control measures, and the cost associated with custom synthesis services. Addressing these challenges through continuous research and development, process optimization, and competitive pricing will be crucial for sustaining the growth of the customized peptide synthesis market.
This report aims to provide a comprehensive presentation of the global market for CMO Peptide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CMO Peptide.
The CMO Peptide market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CMO Peptide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CMO Peptide companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of CMO Peptide Market Report

Report Metric Details
Report Name CMO Peptide Market
Accounted market size in year US$ 3601 million
Forecasted market size in 2031 US$ 9425 million
CAGR 15.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • APIs and Intermediates
  • FDF
Segment by Application
  • Commercial
  • Academic Research
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bachem, PolyPeptide, USV Peptides, Thermofischer, Bio Basic, JPT, Genscript, Xinbang Pharma, ScinoPharm, AmbioPharm, SN Biopharm, CBL, Piramal Pharma, CordenPharma, CPC Scientific
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of CMO Peptide company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is CMO Peptide Market growing?

Ans: The CMO Peptide Market witnessing a CAGR of 15.0% during the forecast period 2025-2031.

What is the CMO Peptide Market size in 2031?

Ans: The CMO Peptide Market size in 2031 will be US$ 9425 million.

Who are the main players in the CMO Peptide Market report?

Ans: The main players in the CMO Peptide Market are Bachem, PolyPeptide, USV Peptides, Thermofischer, Bio Basic, JPT, Genscript, Xinbang Pharma, ScinoPharm, AmbioPharm, SN Biopharm, CBL, Piramal Pharma, CordenPharma, CPC Scientific

What are the Application segmentation covered in the CMO Peptide Market report?

Ans: The Applications covered in the CMO Peptide Market report are Commercial, Academic Research, Other

What are the Type segmentation covered in the CMO Peptide Market report?

Ans: The Types covered in the CMO Peptide Market report are APIs and Intermediates, FDF

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CMO Peptide Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 APIs and Intermediates
1.2.3 FDF
1.3 Market by Application
1.3.1 Global CMO Peptide Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Commercial
1.3.3 Academic Research
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CMO Peptide Market Perspective (2020-2031)
2.2 Global CMO Peptide Growth Trends by Region
2.2.1 Global CMO Peptide Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CMO Peptide Historic Market Size by Region (2020-2025)
2.2.3 CMO Peptide Forecasted Market Size by Region (2026-2031)
2.3 CMO Peptide Market Dynamics
2.3.1 CMO Peptide Industry Trends
2.3.2 CMO Peptide Market Drivers
2.3.3 CMO Peptide Market Challenges
2.3.4 CMO Peptide Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CMO Peptide Players by Revenue
3.1.1 Global Top CMO Peptide Players by Revenue (2020-2025)
3.1.2 Global CMO Peptide Revenue Market Share by Players (2020-2025)
3.2 Global CMO Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CMO Peptide Revenue
3.4 Global CMO Peptide Market Concentration Ratio
3.4.1 Global CMO Peptide Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CMO Peptide Revenue in 2024
3.5 Global Key Players of CMO Peptide Head office and Area Served
3.6 Global Key Players of CMO Peptide, Product and Application
3.7 Global Key Players of CMO Peptide, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CMO Peptide Breakdown Data by Type
4.1 Global CMO Peptide Historic Market Size by Type (2020-2025)
4.2 Global CMO Peptide Forecasted Market Size by Type (2026-2031)
5 CMO Peptide Breakdown Data by Application
5.1 Global CMO Peptide Historic Market Size by Application (2020-2025)
5.2 Global CMO Peptide Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CMO Peptide Market Size (2020-2031)
6.2 North America CMO Peptide Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CMO Peptide Market Size by Country (2020-2025)
6.4 North America CMO Peptide Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CMO Peptide Market Size (2020-2031)
7.2 Europe CMO Peptide Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CMO Peptide Market Size by Country (2020-2025)
7.4 Europe CMO Peptide Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CMO Peptide Market Size (2020-2031)
8.2 Asia-Pacific CMO Peptide Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CMO Peptide Market Size by Region (2020-2025)
8.4 Asia-Pacific CMO Peptide Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CMO Peptide Market Size (2020-2031)
9.2 Latin America CMO Peptide Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CMO Peptide Market Size by Country (2020-2025)
9.4 Latin America CMO Peptide Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CMO Peptide Market Size (2020-2031)
10.2 Middle East & Africa CMO Peptide Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CMO Peptide Market Size by Country (2020-2025)
10.4 Middle East & Africa CMO Peptide Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bachem
11.1.1 Bachem Company Details
11.1.2 Bachem Business Overview
11.1.3 Bachem CMO Peptide Introduction
11.1.4 Bachem Revenue in CMO Peptide Business (2020-2025)
11.1.5 Bachem Recent Development
11.2 PolyPeptide
11.2.1 PolyPeptide Company Details
11.2.2 PolyPeptide Business Overview
11.2.3 PolyPeptide CMO Peptide Introduction
11.2.4 PolyPeptide Revenue in CMO Peptide Business (2020-2025)
11.2.5 PolyPeptide Recent Development
11.3 USV Peptides
11.3.1 USV Peptides Company Details
11.3.2 USV Peptides Business Overview
11.3.3 USV Peptides CMO Peptide Introduction
11.3.4 USV Peptides Revenue in CMO Peptide Business (2020-2025)
11.3.5 USV Peptides Recent Development
11.4 Thermofischer
11.4.1 Thermofischer Company Details
11.4.2 Thermofischer Business Overview
11.4.3 Thermofischer CMO Peptide Introduction
11.4.4 Thermofischer Revenue in CMO Peptide Business (2020-2025)
11.4.5 Thermofischer Recent Development
11.5 Bio Basic
11.5.1 Bio Basic Company Details
11.5.2 Bio Basic Business Overview
11.5.3 Bio Basic CMO Peptide Introduction
11.5.4 Bio Basic Revenue in CMO Peptide Business (2020-2025)
11.5.5 Bio Basic Recent Development
11.6 JPT
11.6.1 JPT Company Details
11.6.2 JPT Business Overview
11.6.3 JPT CMO Peptide Introduction
11.6.4 JPT Revenue in CMO Peptide Business (2020-2025)
11.6.5 JPT Recent Development
11.7 Genscript
11.7.1 Genscript Company Details
11.7.2 Genscript Business Overview
11.7.3 Genscript CMO Peptide Introduction
11.7.4 Genscript Revenue in CMO Peptide Business (2020-2025)
11.7.5 Genscript Recent Development
11.8 Xinbang Pharma
11.8.1 Xinbang Pharma Company Details
11.8.2 Xinbang Pharma Business Overview
11.8.3 Xinbang Pharma CMO Peptide Introduction
11.8.4 Xinbang Pharma Revenue in CMO Peptide Business (2020-2025)
11.8.5 Xinbang Pharma Recent Development
11.9 ScinoPharm
11.9.1 ScinoPharm Company Details
11.9.2 ScinoPharm Business Overview
11.9.3 ScinoPharm CMO Peptide Introduction
11.9.4 ScinoPharm Revenue in CMO Peptide Business (2020-2025)
11.9.5 ScinoPharm Recent Development
11.10 AmbioPharm
11.10.1 AmbioPharm Company Details
11.10.2 AmbioPharm Business Overview
11.10.3 AmbioPharm CMO Peptide Introduction
11.10.4 AmbioPharm Revenue in CMO Peptide Business (2020-2025)
11.10.5 AmbioPharm Recent Development
11.11 SN Biopharm
11.11.1 SN Biopharm Company Details
11.11.2 SN Biopharm Business Overview
11.11.3 SN Biopharm CMO Peptide Introduction
11.11.4 SN Biopharm Revenue in CMO Peptide Business (2020-2025)
11.11.5 SN Biopharm Recent Development
11.12 CBL
11.12.1 CBL Company Details
11.12.2 CBL Business Overview
11.12.3 CBL CMO Peptide Introduction
11.12.4 CBL Revenue in CMO Peptide Business (2020-2025)
11.12.5 CBL Recent Development
11.13 Piramal Pharma
11.13.1 Piramal Pharma Company Details
11.13.2 Piramal Pharma Business Overview
11.13.3 Piramal Pharma CMO Peptide Introduction
11.13.4 Piramal Pharma Revenue in CMO Peptide Business (2020-2025)
11.13.5 Piramal Pharma Recent Development
11.14 CordenPharma
11.14.1 CordenPharma Company Details
11.14.2 CordenPharma Business Overview
11.14.3 CordenPharma CMO Peptide Introduction
11.14.4 CordenPharma Revenue in CMO Peptide Business (2020-2025)
11.14.5 CordenPharma Recent Development
11.15 CPC Scientific
11.15.1 CPC Scientific Company Details
11.15.2 CPC Scientific Business Overview
11.15.3 CPC Scientific CMO Peptide Introduction
11.15.4 CPC Scientific Revenue in CMO Peptide Business (2020-2025)
11.15.5 CPC Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global CMO Peptide Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of APIs and Intermediates
 Table 3. Key Players of FDF
 Table 4. Global CMO Peptide Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global CMO Peptide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global CMO Peptide Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global CMO Peptide Market Share by Region (2020-2025)
 Table 8. Global CMO Peptide Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global CMO Peptide Market Share by Region (2026-2031)
 Table 10. CMO Peptide Market Trends
 Table 11. CMO Peptide Market Drivers
 Table 12. CMO Peptide Market Challenges
 Table 13. CMO Peptide Market Restraints
 Table 14. Global CMO Peptide Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global CMO Peptide Market Share by Players (2020-2025)
 Table 16. Global Top CMO Peptide Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CMO Peptide as of 2024)
 Table 17. Ranking of Global Top CMO Peptide Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by CMO Peptide Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of CMO Peptide, Headquarters and Area Served
 Table 20. Global Key Players of CMO Peptide, Product and Application
 Table 21. Global Key Players of CMO Peptide, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global CMO Peptide Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global CMO Peptide Revenue Market Share by Type (2020-2025)
 Table 25. Global CMO Peptide Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global CMO Peptide Revenue Market Share by Type (2026-2031)
 Table 27. Global CMO Peptide Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global CMO Peptide Revenue Market Share by Application (2020-2025)
 Table 29. Global CMO Peptide Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global CMO Peptide Revenue Market Share by Application (2026-2031)
 Table 31. North America CMO Peptide Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America CMO Peptide Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America CMO Peptide Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe CMO Peptide Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe CMO Peptide Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe CMO Peptide Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific CMO Peptide Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific CMO Peptide Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific CMO Peptide Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America CMO Peptide Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America CMO Peptide Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America CMO Peptide Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa CMO Peptide Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa CMO Peptide Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa CMO Peptide Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Bachem Company Details
 Table 47. Bachem Business Overview
 Table 48. Bachem CMO Peptide Product
 Table 49. Bachem Revenue in CMO Peptide Business (2020-2025) & (US$ Million)
 Table 50. Bachem Recent Development
 Table 51. PolyPeptide Company Details
 Table 52. PolyPeptide Business Overview
 Table 53. PolyPeptide CMO Peptide Product
 Table 54. PolyPeptide Revenue in CMO Peptide Business (2020-2025) & (US$ Million)
 Table 55. PolyPeptide Recent Development
 Table 56. USV Peptides Company Details
 Table 57. USV Peptides Business Overview
 Table 58. USV Peptides CMO Peptide Product
 Table 59. USV Peptides Revenue in CMO Peptide Business (2020-2025) & (US$ Million)
 Table 60. USV Peptides Recent Development
 Table 61. Thermofischer Company Details
 Table 62. Thermofischer Business Overview
 Table 63. Thermofischer CMO Peptide Product
 Table 64. Thermofischer Revenue in CMO Peptide Business (2020-2025) & (US$ Million)
 Table 65. Thermofischer Recent Development
 Table 66. Bio Basic Company Details
 Table 67. Bio Basic Business Overview
 Table 68. Bio Basic CMO Peptide Product
 Table 69. Bio Basic Revenue in CMO Peptide Business (2020-2025) & (US$ Million)
 Table 70. Bio Basic Recent Development
 Table 71. JPT Company Details
 Table 72. JPT Business Overview
 Table 73. JPT CMO Peptide Product
 Table 74. JPT Revenue in CMO Peptide Business (2020-2025) & (US$ Million)
 Table 75. JPT Recent Development
 Table 76. Genscript Company Details
 Table 77. Genscript Business Overview
 Table 78. Genscript CMO Peptide Product
 Table 79. Genscript Revenue in CMO Peptide Business (2020-2025) & (US$ Million)
 Table 80. Genscript Recent Development
 Table 81. Xinbang Pharma Company Details
 Table 82. Xinbang Pharma Business Overview
 Table 83. Xinbang Pharma CMO Peptide Product
 Table 84. Xinbang Pharma Revenue in CMO Peptide Business (2020-2025) & (US$ Million)
 Table 85. Xinbang Pharma Recent Development
 Table 86. ScinoPharm Company Details
 Table 87. ScinoPharm Business Overview
 Table 88. ScinoPharm CMO Peptide Product
 Table 89. ScinoPharm Revenue in CMO Peptide Business (2020-2025) & (US$ Million)
 Table 90. ScinoPharm Recent Development
 Table 91. AmbioPharm Company Details
 Table 92. AmbioPharm Business Overview
 Table 93. AmbioPharm CMO Peptide Product
 Table 94. AmbioPharm Revenue in CMO Peptide Business (2020-2025) & (US$ Million)
 Table 95. AmbioPharm Recent Development
 Table 96. SN Biopharm Company Details
 Table 97. SN Biopharm Business Overview
 Table 98. SN Biopharm CMO Peptide Product
 Table 99. SN Biopharm Revenue in CMO Peptide Business (2020-2025) & (US$ Million)
 Table 100. SN Biopharm Recent Development
 Table 101. CBL Company Details
 Table 102. CBL Business Overview
 Table 103. CBL CMO Peptide Product
 Table 104. CBL Revenue in CMO Peptide Business (2020-2025) & (US$ Million)
 Table 105. CBL Recent Development
 Table 106. Piramal Pharma Company Details
 Table 107. Piramal Pharma Business Overview
 Table 108. Piramal Pharma CMO Peptide Product
 Table 109. Piramal Pharma Revenue in CMO Peptide Business (2020-2025) & (US$ Million)
 Table 110. Piramal Pharma Recent Development
 Table 111. CordenPharma Company Details
 Table 112. CordenPharma Business Overview
 Table 113. CordenPharma CMO Peptide Product
 Table 114. CordenPharma Revenue in CMO Peptide Business (2020-2025) & (US$ Million)
 Table 115. CordenPharma Recent Development
 Table 116. CPC Scientific Company Details
 Table 117. CPC Scientific Business Overview
 Table 118. CPC Scientific CMO Peptide Product
 Table 119. CPC Scientific Revenue in CMO Peptide Business (2020-2025) & (US$ Million)
 Table 120. CPC Scientific Recent Development
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources
 Table 124. Authors List of This Report


List of Figures
 Figure 1. CMO Peptide Picture
 Figure 2. Global CMO Peptide Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global CMO Peptide Market Share by Type: 2024 VS 2031
 Figure 4. APIs and Intermediates Features
 Figure 5. FDF Features
 Figure 6. Global CMO Peptide Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global CMO Peptide Market Share by Application: 2024 VS 2031
 Figure 8. Commercial Case Studies
 Figure 9. Academic Research Case Studies
 Figure 10. Other Case Studies
 Figure 11. CMO Peptide Report Years Considered
 Figure 12. Global CMO Peptide Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global CMO Peptide Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global CMO Peptide Market Share by Region: 2024 VS 2031
 Figure 15. Global CMO Peptide Market Share by Players in 2024
 Figure 16. Global Top CMO Peptide Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CMO Peptide as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by CMO Peptide Revenue in 2024
 Figure 18. North America CMO Peptide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America CMO Peptide Market Share by Country (2020-2031)
 Figure 20. United States CMO Peptide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada CMO Peptide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe CMO Peptide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe CMO Peptide Market Share by Country (2020-2031)
 Figure 24. Germany CMO Peptide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France CMO Peptide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. CMO Peptide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy CMO Peptide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia CMO Peptide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries CMO Peptide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific CMO Peptide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific CMO Peptide Market Share by Region (2020-2031)
 Figure 32. China CMO Peptide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan CMO Peptide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea CMO Peptide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia CMO Peptide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India CMO Peptide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia CMO Peptide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America CMO Peptide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America CMO Peptide Market Share by Country (2020-2031)
 Figure 40. Mexico CMO Peptide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil CMO Peptide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa CMO Peptide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa CMO Peptide Market Share by Country (2020-2031)
 Figure 44. Turkey CMO Peptide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia CMO Peptide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE CMO Peptide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Bachem Revenue Growth Rate in CMO Peptide Business (2020-2025)
 Figure 48. PolyPeptide Revenue Growth Rate in CMO Peptide Business (2020-2025)
 Figure 49. USV Peptides Revenue Growth Rate in CMO Peptide Business (2020-2025)
 Figure 50. Thermofischer Revenue Growth Rate in CMO Peptide Business (2020-2025)
 Figure 51. Bio Basic Revenue Growth Rate in CMO Peptide Business (2020-2025)
 Figure 52. JPT Revenue Growth Rate in CMO Peptide Business (2020-2025)
 Figure 53. Genscript Revenue Growth Rate in CMO Peptide Business (2020-2025)
 Figure 54. Xinbang Pharma Revenue Growth Rate in CMO Peptide Business (2020-2025)
 Figure 55. ScinoPharm Revenue Growth Rate in CMO Peptide Business (2020-2025)
 Figure 56. AmbioPharm Revenue Growth Rate in CMO Peptide Business (2020-2025)
 Figure 57. SN Biopharm Revenue Growth Rate in CMO Peptide Business (2020-2025)
 Figure 58. CBL Revenue Growth Rate in CMO Peptide Business (2020-2025)
 Figure 59. Piramal Pharma Revenue Growth Rate in CMO Peptide Business (2020-2025)
 Figure 60. CordenPharma Revenue Growth Rate in CMO Peptide Business (2020-2025)
 Figure 61. CPC Scientific Revenue Growth Rate in CMO Peptide Business (2020-2025)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart